India Generics Market Summary, Competitive Analysis and Forecast to 2027
Summary
Generics in India industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices.
- The Indian generics market had total revenues of $17.6 billion in 2022, representing a compound annual growth rate (CAGR) of 8.1% between 2017 and 2022.
- Market consumption volume increased with a CAGR of 0.4% between 2017 and 2022, to reach a total of 97.4% in 2022.
- The increasing number of cardiovascular and infectious diseases is boosting the demand for generic medicines across the country. According to the International Diabetes Federation, 77 million people in the country currently have diabetes, which is projected to reach 134 million by 2045.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in India
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in India
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the India generics market with five year forecasts
- What was the size of the India generics market by value in 2022?
- What will be the size of the India generics market in 2027?
- What factors are affecting the strength of competition in the India generics market?
- How has the market performed over the last five years?
- What are the main segments that make up India's generics market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Market volume
- 1.4. Market volume forecast
- 1.5. Geography segmentation
- 1.6. Market rivalry
- 1.7. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 3.2. Market volume
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 5.2. Market volume forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What are the strengths of the leading players?
- 7.3. Have there been any recent developments in the market?
- 8 Company Profiles
- 8.1. Sun Pharmaceutical Industries Ltd
- 8.2. Lupin Ltd
- 8.3. Aurobindo Pharma Ltd
- 8.4. Cipla Limited
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: India generics market value: $ million, 2017-22
- Table 2: India generics market volume: %, 2017-22
- Table 3: India generics market geography segmentation: $ million, 2022
- Table 4: India generics market value forecast: $ million, 2022-27
- Table 5: India generics market volume forecast: %, 2022-27
- Table 6: Sun Pharmaceutical Industries Ltd: key facts
- Table 7: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
- Table 8: Sun Pharmaceutical Industries Ltd: Key Employees
- Table 9: Lupin Ltd: key facts
- Table 10: Lupin Ltd: Annual Financial Ratios
- Table 11: Lupin Ltd: Key Employees
- Table 12: Aurobindo Pharma Ltd: key facts
- Table 13: Aurobindo Pharma Ltd: Annual Financial Ratios
- Table 14: Aurobindo Pharma Ltd: Key Employees
- Table 15: Cipla Limited: key facts
- Table 16: Cipla Limited: Annual Financial Ratios
- Table 17: Cipla Limited: Key Employees
- Table 18: India size of population (million), 2018-22
- Table 19: India gdp (constant 2005 prices, $ billion), 2018-22
- Table 20: India gdp (current prices, $ billion), 2018-22
- Table 21: India inflation, 2018-22
- Table 22: India consumer price index (absolute), 2018-22
- Table 23: India exchange rate, 2018-22
- List of Figures
- Figure 1: India generics market value: $ million, 2017-22
- Figure 2: India generics market volume: %, 2017-22
- Figure 3: India generics market geography segmentation: % share, by value, 2022
- Figure 4: India generics market value forecast: $ million, 2022-27
- Figure 5: India generics market volume forecast: %, 2022-27
- Figure 6: Forces driving competition in the generics market in India, 2022
- Figure 7: Drivers of buyer power in the generics market in India, 2022
- Figure 8: Drivers of supplier power in the generics market in India, 2022
- Figure 9: Factors influencing the likelihood of new entrants in the generics market in India, 2022
- Figure 10: Factors influencing the threat of substitutes in the generics market in India, 2022
- Figure 11: Drivers of degree of rivalry in the generics market in India, 2022
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook